Early mortality rates in older kidney recipients with comorbid risk factors

Transplantation

Volumn 83, Issue 4, 2007, Pages 404-410

  Kauffman, H Myron ^a,d   McBride, Maureen A ^a   Cors, Cynthia S ^a   Roza, Allan M ^b   Wynn, James J ^c  

^a UNITED NETWORK FOR ORGAN SHARING   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d NONE   (United States)

Author keywords

Comorbidities; Kidney recipients; Mortality rates

Indexed keywords

ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ARTICLE; CANCER; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; ADOLESCENT; GENERAL ASPECTS OF DISEASE; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COMORBIDITY; DISEASE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 33947504803     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251780.01031.81     Document Type: Article

References (24)

1. Organ Procurement and Transplantation Network. Available at: http://www.optn.org/latestdata. Accessed October 29, 2005.
2. Cosio FG, Alamir A, Yim S, et al. Patient Survival After Renal Transplantation: I. The Impact of Dialysis Pre-Transplant. Kidney Int 1998; 53: 767.
3. Meier-Kriesche H-U, Kaplan B. Waiting Time on Dialysis as the Strongest Modifiable Factor for Renal Transplant Outcomes: A Paired Donor Kidney Analysis. Transplantation 2002; 74: 1377.
4. Hernandez D, Rufino M, Bartolomei S, et al. A Novel Prognostic Index for Mortality in Renal Transplant Recipients after Hospitalization. Transplantation 2005; 79: 337.
5. Ojo AO, Wolfe RA, Agodoa LY, et al. Prognosis After Primary Renal Transplant Failure and the Beneficial Effects of Repeat Transplantation: Multivariate Analyses from the United States Renal Data System. Transplantation 1998; 66: 1651.
6. Jassal SV, Schaubel DE, Fenton SS. Baseline Comorbidity in Kidney Transplant Recipients: A Comparison of Comorbidity Indices. Am J Kidney Dis 2005; 46: 136.
7. Kauffman HM, Cherikh WS, McBride MA, et al. Transplant Recipients with a History of a Malignancy: Risk of Recurrent and De Novo Cancers. Transplant Rev 2005; 19: 55.
8. Rabbat CG, Treleaven DJ, Russell JD, et al. Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis. J Am Soc Nephrol 2003; 14: 431.
9. Gill JS, Pereira BJ. Death In the First Year After Kidney Transplantation: Implications for Patients on the Transplant Waiting List. Transplantation 2003; 75: 113.
10. Ojo AO, Hanson JA, Meier-Kriesche H-U, et al. Survival in Recipients of Marginal Donor Kidneys Compared with Other Recipients and Wait-Listed Transplant Candidates. J Am Soc Nephrol 2001; 12: 589.
11. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor Characteristics Associated with Reduced Graft Survival: An Approach to Expanding the Pool of Kidney Donors. Transplantation 2002; 74: 1281.
12. Shoskes DA, Cecka JM. Deleterious Effects of Delayed Graft Function in Cadaveric Renal Transplant Recipients Independent of Acute Rejection. Transplantation 1998; 66: 1697.
13. Cherikh WS, Kauffman HM, Maghirang J, et al. A Comparison of Discharge Immunosuppressive Drug Regimens in Primary Cadaveric Kidney Transplantation. Transplantation 2003; 76: 463.
14. United Network for Organ Sharing Policy 3.5.11.1. Available at: http://www.UNOS.org/policiesandbylaws/policies/docs/policy_7.doc. Accessed July 29, 2005.
15. Arrigada R, Rutqvist LE, Kramar A, Johansson H. Competing Risks Determining Event-Free Survival in Early Breast Cancer. Br J Cancer 1992; 66: 951.
16. Meier-Kriesche H-U, Friedman G, Jacobs M, et al. Infectious Complications in Geriatric Renal Transplant Patients: Comparison of Two Immunosuppressive Protocols. Transplantation 1999; 68: 1496.
17. Smits JMA, Persijn GG, van Houwelingen HC, et al. Evaluation of the Eurotransplant Senior Program. The Results of the First Year. Am J Transplant 2002; 2: 664.
18. Oniscu GC, Brown H, Forsythe JL. How Old is Old for Transplantation? Am J Transplant 2004; 4: 2067.
19. United Network for Organ Sharing Policy 3.5.1. Available at: http://www.UNOS.org/policiesandbylaws/policies/docs/policy_7.doc. Accessed January 18, 2006.
20. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-Donor Characteristics and the Survival Benefit of Kidney Transplantation. JAMA 2005; 294: 2726.
21. Marcen R, Orofino L, Pascual J, et al. Delayed Graft Function Does Not Reduce the Survival of Renal Transplant Allografts. Transplantation 1998; 66: 461.
22. Ojo AO, Wolfe RA, Held PJ, et al. Delayed Graft Function: Risk Factors and Implications for Renal Allograft Survival. Transplantation 1997; 63: 968.
23. United Network for Organ Sharing Policy 3.5.11.5.2. Available at: http://www.UNOS.org/policiesandbylaws/policies/docs/policy_7.doc. Accessed January 16, 2006.
24. Schnitzler MA, Whiting JF, Brennan DC, et al. The Life-Years Saved by a Deceased Organ Donor. Am J Transplant 2005; 5: 2289.